~~<i id='1502BB7DA6'><strike id='1502BB7DA6'><tt id='1502BB7DA6'><pre id='1502BB7DA6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：entertainment 2025-10-01 18:34:57 - browse：33559

J.P. Morgan office building at night -- JPM health business coverage from STAT — Adobe

SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so.

Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

Their message? We’re still here.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Amylyx ALS drug failure raises questions and concerns

entertainment

explore

knowledge

leisure time

explore

hotspot

MollyFergusonforSTATZariawasjust9yearsoldwhenanursepractitionerdeliverednewsthatrockedherworld:Theyo

WSS

UnitedHealth quietly bought dozens of outpatient centers

Biogen Alzheimer’s drug launch off to slow start

Industry veterans launch new biotech VC with $310M

Biden report: The neurospychology of memory and aging

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

leisure time

explore

entertainment

What does generative AI mean for health care? We asked experts

Biden report: The neurospychology of memory and aging

Alkermes shareholders re

Precocious puberty in girls comes with mental health risks

Dobbs anniversary: the lost opportunity of abortion as health care

The Readout: Gilead, Bernie Sanders, and other pharma news

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

How to save PrEP access — and even expand it

Novo Nordisk obesity pill bests Wegovy in early trial

explore

Key House Republican on health care plans exit from Congress

Vaccine advisory panel ACIP left half staffed by HHS

BioAge raises $170M for combination therapy with Zepbound

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

The Readout: Gilead, Bernie Sanders, and other pharma news

Readout LOUD podcast: How biotech is using artificial intelligence

knowledge

leisure time

explore

hotspot